🇺🇸 FDA
Pipeline program

BG-68501

BG-68501-101

Phase 1 small_molecule active

Quick answer

BG-68501 for Breast Cancer is a Phase 1 program (small_molecule) at BeOne Medicines with 1 ClinicalTrials.gov record(s).

Program details

Company
BeOne Medicines
Indication
Breast Cancer
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials